L17E selectively directs its actions towards critical immune cells, thereby mitigating inflammation and impeding the progression of debilitating ailments. Through an array of exceptional preclinical investigations, L17E has exhibited remarkable outcomes and presents an unprecedented mechanism of action, instilling steadfast hope towards a paradigm shift in the realm of autoimmune disease management.
CAT# | GR2206 |
CAS | 2305578-13-4 |
M.F/Formula | C134H219N37O32S |
M.W/Mr. | 2860.41 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
MCL 0020 is a synthetic tripeptide with the structure of Ac-D-2Nal-Arg-2Nal-NH2 (2-Nal= 3-(2-naphthyl)-L-alanine ...
Antioxidant effect of peptides Peptides have been isolated from the resultant by-products in the past 15 years and suggested ...
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...
What are collagen peptides? Collagen peptides are repair collagen, and the protein slowly decreases with age. It can be see ...
Antazoline is a drug used in the treatment of atrial fibrillation (AF), and its formula is C17H19N3. In fact, th ...